INDEMNITY AGREEMENTIndemnity Agreement • February 3rd, 2021 • EQ Health Acquisition Corp. • Blank checks • Delaware
Contract Type FiledFebruary 3rd, 2021 Company Industry JurisdictionTHIS INDEMNITY AGREEMENT (this “Agreement”) is made as of January 28, 2021, by and between EQ Health Acquisition Corp., a Delaware corporation (the “Company”), and Andrew Beckman (“Indemnitee”).
WARRANT AGREEMENTWarrant Agreement • February 3rd, 2021 • EQ Health Acquisition Corp. • Blank checks • New York
Contract Type FiledFebruary 3rd, 2021 Company Industry JurisdictionTHIS WARRANT AGREEMENT (this “Agreement”), dated as of January 28, 2021, is by and between EQ Health Acquisition Corp., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York limited purpose trust company, as warrant agent (the “Warrant Agent”, also referred to herein as the “Transfer Agent”).
INVESTMENT MANAGEMENT TRUST AGREEMENTInvestment Management Trust Agreement • February 3rd, 2021 • EQ Health Acquisition Corp. • Blank checks • New York
Contract Type FiledFebruary 3rd, 2021 Company Industry JurisdictionPursuant to Section 1(k) of the Investment Management Trust Agreement between EQ Health Acquisition Corp. (the “Company”) and Continental Stock Transfer & Trust Company (the “Trustee”), dated as of , 2021 (the “Trust Agreement”), the Company hereby requests that you deliver to the redeeming Public Stockholders of the Company $[ ] of the principal and interest income earned on the Property as of the date hereof to a segregated account held by you on behalf of the Beneficiaries for distribution to the Public Stockholders who have requested redemption of their shares of Common Stock. Capitalized terms used but not defined herein shall have the meanings set forth in the Trust Agreement.
REGISTRATION AND STOCKHOLDER RIGHTS AGREEMENTRegistration and Stockholder Rights Agreement • February 3rd, 2021 • EQ Health Acquisition Corp. • Blank checks • New York
Contract Type FiledFebruary 3rd, 2021 Company Industry JurisdictionTHIS REGISTRATION AND STOCKHOLDER RIGHTS AGREEMENT (this “Agreement”), dated as of January 28, 2021, is made and entered into by and among EQ Health Acquisition Corp., a Delaware corporation (the “Company”), EQ Health Sponsor Group, LLC, a Delaware limited liability company (the “Sponsor”), and the undersigned parties listed under Holder on the signature page hereto (each such party, together with the Sponsor, members of the Sponsor and any person or entity who hereafter becomes a party to this Agreement pursuant to Section 6.2 of this Agreement, a “Holder” and collectively the “Holders”).
19,130,400 Units EQ HEALTH ACQUISITION CORP. UNDERWRITING AGREEMENTUnderwriting Agreement • February 3rd, 2021 • EQ Health Acquisition Corp. • Blank checks • New York
Contract Type FiledFebruary 3rd, 2021 Company Industry JurisdictionIntroductory. EQ Health Acquisition Corp., a Delaware corporation (the “Company”), proposes, upon the terms and conditions set forth in this agreement (this “Agreement”), to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 19,130,400 units of the Company (the “Units”). The 19,130,400 Units to be sold by the Company are called the “Firm Securities.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional 2,869,560 Units as provided in Section 2. The additional 2,869,560 Units to be sold by the Company pursuant to such option are collectively called the “Optional Securities.” The Firm Securities and, if and to the extent such option is exercised, the Optional Securities are collectively called the “Offered Securities.” Jefferies LLC (“Jefferies”) has agreed to act as representative of the Underwriters (in such capacity, the “Representative”) in connection with the offering of the Offered Securit
WARRANT PURCHASE AGREEMENTWarrant Purchase Agreement • February 3rd, 2021 • EQ Health Acquisition Corp. • Blank checks • New York
Contract Type FiledFebruary 3rd, 2021 Company Industry JurisdictionTHIS WARRANT PURCHASE AGREEMENT (as it may from time to time be amended, this “Agreement”), dated as of January 28, 2021, is entered into by and among EQ Health Acquisition Corp., a Delaware corporation (the “Company”), and EQ Health Sponsor Group, LLC, a Delaware limited liability company (the “Purchaser”).
EQ Health Acquisition CorporationLetter Agreement • February 3rd, 2021 • EQ Health Acquisition Corp. • Blank checks
Contract Type FiledFebruary 3rd, 2021 Company IndustryThis letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) to be entered into by and among EQ Health Acquisition Corp., a Delaware corporation (the “Company”), and Jefferies LLC, as representative (the “Representative”) of the several underwriters (each, an “Underwriter” and collectively, the “Underwriters”), relating to an underwritten initial public offering (the “Public Offering”), of 21,999,960 of the Company’s units (including up to 2,869,560 units that may be purchased to cover over-allotments, if any) (the “Units”), each comprised of one share of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”), and one half of one redeemable warrant. Each whole warrant (each, a “Warrant”) entitles the holder thereof to purchase one share of Common Stock at a price of $11.50 per share, subject to adjustment. The Units will be sold in the Public Offering pursuant to a registration
EQ HEALTH ACQUISITION CORP.Letter Agreement • February 3rd, 2021 • EQ Health Acquisition Corp. • Blank checks • New York
Contract Type FiledFebruary 3rd, 2021 Company Industry JurisdictionThis letter agreement by and between EQ Health Acquisition Corp. (the “Company”) and EQ Capital Strategies, LLC (“EQ Capital”), dated as of the date hereof, will confirm our agreement that, commencing on the effective date (the “Effective Date”) of the Registration Statement on Form S-1 filed with the U.S. Securities and Exchange Commission (the “Registration Statement”) for the Company’s initial public offering and continuing until the earlier of the consummation by the Company of an initial business combination or the Company’s liquidation (in each case as described in the Registration Statement) (such earlier date hereinafter referred to as the “Termination Date”):